Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06246110

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Led by Eikon Therapeutics · Updated on 2025-11-12

70

Participants Needed

39

Research Sites

199 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is for patients with advanced/metastatic non-small cells lung cancer (NSCLC) who have not received any treatment through the vein for the advanced disease.

CONDITIONS

Official Title

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be 18 years of age or older at the time of consent
  • Have confirmed stage 4 non-small cell lung cancer, either squamous or non-squamous type
  • Have no tumor mutations or fusions that indicate need for mutation-directed therapy
  • Have at least one measurable tumor lesion at baseline according to RECIST 1.1
  • Have not received prior systemic treatment for advanced or metastatic NSCLC
  • Have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 1
  • Have adequate organ function as determined by study assessments
Not Eligible

You will not qualify if you...

  • Have NSCLC that is not predominantly squamous or non-squamous cell histology
  • Have participated in another investigational agent study or received investigational therapy within 4 weeks or 5 half-lives before starting EIK1001
  • Have received prior systemic therapy for metastatic disease or had major surgery less than 3 weeks before starting EIK1001
  • Have completed palliative radiotherapy within 7 days before the first study drug dose
  • Have a history of prior malignancy unless treated curatively with no recurrence for 5 years
  • Have an active infection requiring treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 39 locations

1

Southern Cancer Care

Daphne, Alabama, United States, 36608

Actively Recruiting

2

Ironwood Cancer and Research Center

Chandler, Arizona, United States, 85224

Actively Recruiting

3

California Cancer Care Associates for Research & Excellence

Fresno, California, United States, 93720

Actively Recruiting

4

California Research Institute

Los Angeles, California, United States, 90027

Actively Recruiting

5

University of Southern California, Norris Comprehensive Cancer Center

Los Angeles, California, United States, 90033

Actively Recruiting

6

Providence St Joseph Hospital, Center for Cancer Prevention and Treatment

Orange, California, United States, 92868

Actively Recruiting

7

Sutter Health Institute for Medical Research

Sacramento, California, United States, 95816

Actively Recruiting

8

Rocky Mountain Cancer

Lone Tree, Colorado, United States, 80124

Actively Recruiting

9

Bioresearch Partner

Hialeah, Florida, United States, 33013

Actively Recruiting

10

Memorial Cancer Institute

Hollywood, Florida, United States, 33021

Actively Recruiting

11

Mid-Florida Hematology and Oncology Center

Orange, Florida, United States, 32763

Actively Recruiting

12

Orlando Health Cancer Institute

Orlando, Florida, United States, 32806

Actively Recruiting

13

Moffitt Cancer Center

Tampa, Florida, United States, 33612

Not Yet Recruiting

14

Atlanta Piedmont Hospital

Atlanta, Georgia, United States, 30318

Not Yet Recruiting

15

Kaiser Permanente Hawaii

Honolulu, Hawaii, United States, 96819

Actively Recruiting

16

Illinois Cancer Specialists

Niles, Illinois, United States, 60714

Actively Recruiting

17

Accelacare of Duly

Tinley Park, Illinois, United States, 60487

Actively Recruiting

18

Indiana University Cancer Center

Indianapolis, Indiana, United States, 46202

Actively Recruiting

19

Health Midwest Oncology Associates of Kansas

Overland Park, Kansas, United States, 66211

Actively Recruiting

20

Cancer Center of Kansas

Wichita, Kansas, United States, 67214

Actively Recruiting

21

Medstar Franklin Square Cancer Center at Loch Raven Campus

Baltimore, Maryland, United States, 21237

Actively Recruiting

22

Maryland Oncology

Columbia, Maryland, United States, 20144

Actively Recruiting

23

Jersey Shore University Medical Center/Meridian Hematology & Oncology

Neptune City, New Jersey, United States, 07753

Actively Recruiting

24

New York Cancer and Blood Specialists

Babylon, New York, United States, 11702

Actively Recruiting

25

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health

New York, New York, United States, 10016

Actively Recruiting

26

Weil Cornell Medical Center

New York, New York, United States, 10022

Actively Recruiting

27

Albert Einstein College of Medicine, Jacobi Medical Center

The Bronx, New York, United States, 10461

Actively Recruiting

28

Cancer and Blood Specialists of New York, White Plains Hospital

White Plains, New York, United States, 10601

Actively Recruiting

29

Messino Cancer Centers

Asheville, North Carolina, United States, 28806

Actively Recruiting

30

Gabrail Cancer Center

Canton, Ohio, United States, 44718

Actively Recruiting

31

Willamette Valley

Eugene, Oregon, United States, 97401

Actively Recruiting

32

Tennessee Cancer Specialists

Knoxville, Tennessee, United States, 37909

Actively Recruiting

33

Baptist Cancer Center

Memphis, Tennessee, United States, 38120

Actively Recruiting

34

Texas Oncology, Austin

Austin, Texas, United States, 78745

Actively Recruiting

35

Texas Oncology, Bedford

Bedford, Texas, United States, 76022

Actively Recruiting

36

The Center for Cancer and Blood Disorders

Fort Worth, Texas, United States, 76104

Actively Recruiting

37

Blue Ridge Cancer Care Oncology Associates SW VA

Blacksburg, Virginia, United States, 24060

Actively Recruiting

38

Virginia Cancer Specialists

Fairfax, Virginia, United States, 22031

Actively Recruiting

39

Shenandoah Oncology

Winchester, Virginia, United States, 22601

Actively Recruiting

Loading map...

Research Team

G

Genevieve Doster

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here